(Q51971456)

19 April 2018

title

Receipt of psychotropic medication by people with intellectual disability in residential settings. (English)

1 reference

19 April 2018

disability affecting intellectual abilities

main subject

intellectual disability

1 reference

based on heuristic

inferred from title

1 reference

J Robertson

1

1 reference

19 April 2018

E Emerson

2

1 reference

19 April 2018

N Gregory

3

1 reference

19 April 2018

C Hatton

4

1 reference

19 April 2018

S Kessissoglou

5

1 reference

19 April 2018

A Hallam

6

1 reference

19 April 2018

publication date

1 December 2000

1 reference

19 April 2018

Journal of Intellectual Disability Research

published in

1 reference

19 April 2018

volume

44 ( Pt 6)

1 reference

19 April 2018

page(s)

666-676

1 reference

19 April 2018

City-wide survey of drug patterns among non-institutionalized mentally retarded persons.

cites work

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2788.2000.00307.X

Antipsychotic medication for challenging behaviour in people with intellectual disability: a systematic review of randomized controlled trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2788.2000.00307.X

Weight gain in adolescents treated with risperidone and conventional antipsychotics over six months

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2788.2000.00307.X

The use of anti‐psychotic drugs with adults with learning disabilities and challenging behaviour

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2788.2000.00307.X

Reliability and validity of the PAS-ADD Checklist for detecting psychiatric disorders in adults with intellectual disability.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2788.2000.00307.X

Reduction in antipsychotic drug dosage in mentally handicapped patients. A hospital study

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2788.2000.00307.X

10.1046/J.1365-2788.2000.00307.X

21 January 2018

Identifiers

DOI

1 reference

19 April 2018

PubMed ID

11115021

1 reference

19 April 2018